Mannoprotein Cig1 contributes to the immunogenicity of a heat-killed F-box protein Fbp1 Cryptococcus neoformans

Samantha L Avina1,2, Siddhi Pawar1,2, Roshni N Kadam1,2

  • 1School of Graduate Studies at the Health Science Campus, New Jersey Medical School, Rutgers University Newark, Newark, New Jersey, USA.

Infection and Immunity
|November 28, 2025
PubMed

Insights

The heat-killed *Cryptococcus neoformans* fbp1Δ mutant vaccine shows promise, with Cig1 identified as a key antigen enhancing protection against fungal infections by boosting immune responses.

Area of Science:

  • Mycology
  • Immunology
  • Vaccinology

Background:

  • Fungal infections cause over 1.5 million deaths annually, with no existing clinical fungal vaccine.
  • A *Cryptococcus neoformans* mutant strain, *fbp1*Δ, has shown potential as a vaccine candidate, inducing an interferon gamma (IFN-γ)-dependent immune response.
  • The specific immunogenic factors responsible for the protective effects of the heat-killed *fbp1*Δ (HK-*fbp1*) vaccine remain unidentified.

Purpose of the Study:

  • To identify the immunogenic factors in the HK-*fbp1* vaccine responsible for protective immunity against fungal infections.
  • To investigate the role of the fungal capsule and Cytokine Inducing Glycoprotein 1 (Cig1) in the efficacy of the HK-*fbp1* vaccine.

Main Methods:

  • Comparative analysis of acapsular HK-*fbp1* cells versus encapsulated cells in protection studies.
  • Genetic manipulation of the *fbp1*Δ mutant to assess the impact of Cig1 deletion on vaccine efficacy.
  • Evaluation of immune responses, including T cell recruitment and cytokine production, in vaccinated hosts challenged with *C. neoformans*.

Main Results:

  • Acapsular HK-*fbp1* cells demonstrated diminished protection against wild-type fungal challenge, highlighting the capsule's importance.
  • Cytokine Inducing Glycoprotein 1 (Cig1), regulated by Fbp1, was identified as a significant contributor to HK-*fbp1* immunogenicity.
  • Deletion of Cig1 in the *fbp1*Δ mutant led to reduced antifungal T cell recruitment, lower protective cytokine levels, and decreased survival rates at lower vaccine doses.

Conclusions:

  • The fungal capsule and Cig1 are critical components contributing to the protective efficacy of the HK-*fbp1* vaccine.
  • Cig1 is a key antigen that enhances the immunogenicity of the HK-*fbp1* vaccine.
  • Further optimization of the HK-*fbp1* vaccine by leveraging Cig1 could provide a valuable tool against invasive fungal infections.